Table 1.
Analytical data on 126 patients with non diabetic nephropathies at baseline and at the last observation during follow-up.
| Sample Size | Age (years) |
Follow-up (months) |
Baseline GFR (ml/min/1.73 m2) (inulin clearance) |
Baseline creatinine (μmol/L) |
Number of GFR measurements | Final GFR (ml/min/1.73 m2) (inulin clearance) |
Final Creatinine (μmol/L) |
|
|---|---|---|---|---|---|---|---|---|
| Whole group | 126 | 40.36 ± 12.48 [17–69] |
37.56 ± 27.04 [6–117] |
71.03 ± 24.02 [20–138] |
119.03 ± 50.85 [49–319] |
3.43 ± 2.06 [2–11] |
71.19 ± 26.93 [18–140] |
123.24 ± 69.195 [53–485] |
| Patients with deterioration in renal function | 65 | 39.15 ± 12.50 [20–65] |
42.86 ± 29.47 [6–117] |
75.30 ± 26.15 [20–138] |
123.15 ± 57.85 [49–316] |
3.72 ± 2.2 [2–11] |
61.67 ± 25.49 [18–118] |
141.81 ± 85.97 [63–485] |
| Patients with improvement in renal function | 61 | 41.65 ± 12.43 [17–69] |
31.91 ± 23.11 [6–93] |
66.47 ± 20.78 [24–124] |
114.81 ± 42.21 [53–285] |
3.13 ± 1.8 [2–10] |
81.32 ± 24.79 [25–140] |
103.45 ± 36.31 [53–247] |
Data are expressed as means ± SD [range]